Task area b-2; POP 09/14/2020-03/20/2023; dait/biod can 8470039; $599,404.00
Active Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,404
Award facts
- Opportunity
-
- NIH tetramer core facility Pre-Solicitation · Posted Sep 11, 2018
- Contract value 100% obligated
- $599,403.88 Current and potential, with all options
- Completion date 94% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Atlanta, GA 30322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $599,404 |
About this award
Emory University, a private research institution located in Atlanta, Georgia, was awarded a delivery order valued at approximately $599.4K by the National Institute of Allergy and Infectious Diseases (NIAID) under Task Area B-2. This cost-plus-no-fee delivery order, issued on September 8, 2020, supports research activities with a period of performance extending through March 20, 2025, and an ultimate completion date of March 20, 2027. The contract was not set aside for any specific socioeconomic category, reflecting Emory's competitive technical capabilities in biomedical research. The award was structured as a delivery order against an existing contract vehicle, with the initial obligation subsequently deobligated and reobligated with a 12-month no-cost extension to accommodate the extended performance schedule.
This engagement aligns with NIAID's core mission of conducting and supporting research on infectious diseases and related conditions. Emory University's extensive portfolio of federal research awards demonstrates its established expertise in infectious disease studies, biomedical research, and clinical investigations—capabilities directly relevant to NIAID's research objectives. The university's track record securing competitive federal contracts across multiple institutes and agencies, combined with its research infrastructure in Atlanta, positions it as a capable partner for the institute's investigative priorities under this delivery order.
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 8, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $599,404 on 75N93020F00003.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under 75N93020D00005, an indefinite delivery contract.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award